The progressive loss of midbrain (MB) dopaminergic (DA) neurons defines the motor features of 31 Parkinson disease (PD) and modulation of risk by common variation in PD has been well established 32 through GWAS. Anticipating that a fraction of PD-associated genetic variation mediates their effects 33 within this neuronal population, we acquired open chromatin signatures of purified embryonic mouse 34 MB DA neurons. Correlation with >2,300 putative enhancers assayed in mice reveals enrichment for MB 35 cis-regulatory elements (CRE), data reinforced by transgenic analyses of six additional sequences in 36 zebrafish and mice. One CRE, within intron 4 of the familial PD gene SNCA, directs reporter expression in 37 catecholaminergic neurons of transgenic mice and zebrafish. Sequencing of this CRE in 986 PD patients 38 and 992 controls reveals two common variants associated with elevated PD risk. To assess potential 39 mechanisms of action, we screened >20,000 DNA interacting proteins and identify a subset whose 40 binding is impacted by these enhancer variants. Additional genotyping across the SNCA locus identifies a 41 single PD-associated haplotype, containing the minor alleles of both of the aforementioned PD-risk 42 variants. Our work posits a model for how common variation at SNCA may modulate PD risk and 43 highlights the value of cell context-dependent guided searches for functional non-coding variation. 44 48 phenotypes observed in PD. While this disorder affects approximately 1% of people over 70 years old 49 worldwide 3 , the mechanisms underlying genetic risk of sporadic PD in the population remains largely 50 unknown. Familial cases of PD with known pathogenic mutations are better understood but account for 51 ≤10% of PD cases 4 . 52
INTRODUCTION 45
Parkinson disease (PD) is a common progressive neurodegenerative disorder characterized by 46 preferential and extensive degeneration of dopaminergic (DA) neurons in the substantia nigra 1,2 . This loss of midbrain (MB) DA neurons disrupts the nigrostriatal pathway and results in the movement non-coding variation to PD risk. To maximize the specificity of the biological context, we generated 75 chromatin signatures of purified mouse MB and FB DA neurons. We examined the resulting regulatory 76 regions for their ability to direct in vivo reporter expression and developed a regulatory sequence 77 vocabulary specific to DA neurons. In doing so, we identified a novel MB DA regulatory element that falls 78 within intron 4 of SNCA and demonstrate its ability to direct reporter expression in catecholaminergic 79 neurons of transgenic mice and zebrafish. Furthermore, this enhancer harbours two common variants 80 falling in a haplotype that we determine to be associated with PD risk. We demonstrate these enhancer 81 variants impact protein binding and we propose a model for how the variants and the haplotype at large 82 contribute to SNCA regulatory control. This work illustrates the power of cell context-dependent guided 83 searches for the identification of disease associated and functional non-coding variation. 84
RESULTS

85
ATAC-seq identifies open chromatin in MB and FB DA neurons 86
To identify regions of open chromatin in DA neurons, we performed ATAC-seq 17 on ~50,000 fluorescent-87 activated cell sorting (FACS)-isolated cells (per replicate) from microdissected regions of the MB and FB 88 of embryonic day 15.5 (E15.5) Tg(Th-EGFP)DJ76Gsat BAC transgenic mice 18 (Figure 1a) . This mouse line 89 expresses EGFP under the control of the tyrosine hydroxylase (Th) locus, labeling catecholaminergic 90 neurons (i.e.: DA, noradrenergic, and adrenergic neurons). To confirm capture of the corresponding 91 catecholaminergic neurons, we performed RT-qPCR on the isolated reporter-labelled cells, establishing 92 them to be enriched for DA neuronal markers relative to unlabelled populations from the same 93 dissected tissues (Supplemental Figure 1) . 94
To evaluate the ATAC-seq libraries, we examined the called peaks and read pile-ups with the Integrative 95 Genomics Viewer (IGV) 19, 20 and quantified the correlation between brain regions and within replicates. A 96 representative browser trace at the Th locus in both MB and FB libraries is presented in Figure 1b . 97
Replicates are well correlated: MB library replicates have an average correlation of 0.72 (Figure 1c) , and 98 FB replicates are more correlated at r = 0.86 (Figure 1d) . Given the robust correlation between 99 replicates, we pooled all reads from the same brain region and called peaks on this unified set to To assess these catalogues for characteristics of functionality, we examined the sequence constraint 105 underlying the called regions of open chromatin, excluding peaks that overlap promoters. Promoters are 106 typically accessible 21 and thus, we aimed to reduce the inflation of sequence conservation due to highly 107 conserved promoter-overlapping ATAC-seq peaks. Despite removal of these highly conserved peaks, we 108 observed a high degree of sequence constraint underlying open chromatin peaks compared to 109 background (Figure 1e) . The fact that elements in these libraries of putative cis-regulatory elements 110 (CREs) are constrained, highlights their likely functional significance. 111
To further examine the catalogues for biological relevance, we explored the gene ontology (GO) terms 112 of nearby genes. While CREs are not restricted to acting solely on the nearest gene, this restriction is 113 often used as a proxy in the absence of other information. To bolster our predictions, we also generated 114 bulk RNA-seq data on these same populations of sorted cells and used these data to examine the GO 115 terms of the nearest expressed gene (RPKM ≥ 1). While still imperfect, implementing this as a proxy for 116 function results in GO terms enriched for neuronal functions in both MB and FB catalogues (Figures 1f,  117 g). Thus, we establish these catalogues are enriched for putative CREs likely directing the expression of 118 genes with key roles in neuronal biology. 119
Candidate regulatory regions are capable of directing expression in vivo 120
Although our candidate CRE catalogues appear to be enriched for functional elements on the basis of 121 sequence conservation and GO, both of these metrics are indirect surrogates for true measures of 122 function. To more directly measure the biological relevance of the catalogues and to identify enhancers, 123
we assessed the capability of the candidate CREs to direct expression in vivo. 124
We took advantage of the large repository of elements that have already been tested in lacZ reporter 125 catalogues. Stratifying these confirmed neuronal enhancers on the basis of their expression patterns in 135 VISTA, we observed an abundance of MB-specific enhancers in our MB catalogue, and an abundance of 136 FB-specific enhancers in our FB catalogue, with 77% of MB-and FB-specific enhancers in VISTA captured 137 in our MB and FB catalogues, respectively (Figure 2c) . Collectively, these data establish that our region-138 specific catalogues capture region-specific, active CREs with high efficiency. 139
To extend our assessment of the biological activity of sequences within these catalogues, we focused on 140 an additional five candidate CREs not already tested in the VISTA browser and evaluated their ability to 141 act as enhancers in lacZ reporter mice and in transgenic zebrafish TdTomato reporter assays. All five 142 regions were represented by robust peaks in both the MB and FB catalogues (Supplemental Figure 3) . 143
Two regions, one in the first intron of Kcnq3 and the other downstream of Foxg1, were additionally 144 prioritized using H3K27Ac ChIP-seq from a variety of tissues from E11.5 and E15.5 embryonic mice, 145 seeking to limit our selection to candidate enhancers predicted to have neuronal-specific activity. The 146 remaining three candidate CREs were selected on their proximity to genes important in DA neuron 147 biology. We selected sequences at Foxa2 and Nr4a2, as both are key transcription factors (TFs) in the 148 development and maintenance of DA neurons 23-26 . The final region, located in an intron of Crhr1, was 149 selected as this locus has been implicated in PD by GWAS 9 and our group has recently prioritized this 150 gene as a candidate for PD risk 27 . All selected sequences were lifted over to hg19, facilitating the 151 identification and assay of their corresponding human sequence intervals. 152
When tested in transgenic reporter mice at E11.5 (Supplemental Figure 3) , two of the five regions 153 (those near KCNQ3 and FOXA2) were validated as enhancers (Figure 2c, g) . Recognizing that a disparity 154 exists between the developmental time at which we generated the catalogues (E15.5) and when the 155 data was assayed (E11.5), which may compromise validation rates, we also assayed each sequence 156 across multiple time points in zebrafish. All assayed regions except that at KCNQ3 directed reporter 157 expression in mosaic transgenic zebrafish (Figures 2d, e, To identify sequence modules (kmers) predicted to contribute regulatory activity of putative CREs in our 165 catalogues, we applied the machine learning algorithm, gkm-SVM 28 . The resulting regulatory 166 vocabularies of kmers had high predictive power (auROC MB = 0.915, auROC FB = 0.927). We rank ordered 167 and collapsed related kmers to reveal motifs enriched in the putative CREs and their corresponding TFs 168 (Figures 3a, e, i, m) . In the MB, the four most enriched motifs correspond to Rfx1, Foxa2, Ascl2, and 169 Nr4a2. Given the degeneracy of binding motifs within TF families, we consulted the bulk RNA-seq data 170 for each of the implicated TF families and examined the relative expression levels to prioritize which TFs 171 are most likely producing the observed motif enrichments (Figures 3b, f, 
j, n). While no member of the 172
Rfx family has been canonically associated with MB DA neurons, we anticipate Rfx3 and Rfx7, as the two 173 highest expressed Rfx genes, to likely be active in MB DA neurons and driving this motif enrichment 174 (Figure 3b) . Foxa1, and more specifically, Foxa2 are both known to DA neuron biology 23,29 and both are 175 highly expressed in the MB DA neurons (Figure 3f ). Regarding enrichment for the Ascl family, Ascl1 is 176 known to be involved in DA neuron biogenesis 30 and is more highly expressed than any other TF in the 177 family (Figure 3j ). Finally, Nr4a2 is both canonically associated with DA neurons and required for their 178 development 26 ; we observe it to be highly expressed in MB DA neurons (Figure 3n ). Examining the 179 sequences underlying the CRE catalogues, we identified TF families known and unknown to DA neuron 180 biology and further refined the TF associations using expression data. 181
We also examined the qualities that differentiate MB CREs from FB CREs by examining the sequences 182 underlying MB-specific and FB-specific regions. We developed a vocabulary that discriminates MB and 183 FB regions with high predictive power (auROC = 0.926) and identified kmers enriched in MB-specific 184 peaks where the top corresponding TFs are Foxa1/2 and Nr4a2 (Supplemental Figure 4) . We confirmed 185 this MB bias by again considering the bulk RNA-seq for these genes. As expected, these TFs are more 186 highly expressed in the MB where Nr4a2 is present at 12-fold higher levels in the MB (135 RPKM in the 187 MB vs 11 RPKM in the FB) and Foxa1/2 are not expressed in the FB, but are present in the MB (Foxa1: 28 188 RPKM, Foxa2: 7 RPKM). Not only do we identify Foxa1/2 and Nr4a2 as more active in MB DA neurons 189 than in the FB, we did so solely by comparing their role in the vocabulary of MB-specific candidate CREs 190 versus FB-specific CREs. 191
In a parallel strategy to identify TFs actively engaging the DNA in MB DA neurons, we performed TF 192 footprinting in a single deeply sequenced MB ATAC-seq library. Doing so, we confirm that two of the TFs 193 prioritized by gkm-SVM leave robust footprints. The motif corresponding to Rfx binding results in a dearth of cuts directly over predicted binding sites (Figure 3c) . The same can be seen to a lesser extent 195 for the motif corresponding to Foxa1/2 (Figure 3g) . By contrast, motifs corresponding to Ascl1 or Nr4a2 196 fail to leave a robust mark on the chromatin availability (Figures 3k, o) . These footprinting data 197 substantiate the claim that the Rfx family of TFs and Foxa1/2 are active in MB DA neuron CREs. 198 We confirmed that these sequences are indeed enriched in the catalogues by examining the pileup of 199 reads overlapping all genome-wide predicted motif binding sites for each motif identified by gkm-SVM. 200 We see an abundance of reads over predicted binding sites of all four motifs (Figures 3d, h, 
A candidate CRE in intron 4 of SNCA is associated with PD risk 208
Having established the biological robustness of the CRE catalogue, we moved to exploit these data to 209 investigate how non-coding variation therein may be contributing to PD risk; given α-synuclein's 210 established role in PD pathogenesis, we prioritized this locus for investigation. We first noted that Snca 211 expression differs significantly between the MB and FB DA neurons in our bulk RNA-seq (Figure 4b) . 212
Examining the chromatin accessibility at the Snca locus, the MB and FB are largely the same with the 213 exception of one robust peak in intron 4 (mm9: chr6:60,742,503-60,744,726) that is present in the MB 214 and completely absent in the FB (Figure 4a ). DNase hypersensitivity site (DHS) linkage 21,31 suggests that 215 this putative CRE interacts with the SNCA promoter. Given the MB-specificity of this putative CRE and 216 indications that it interacts with the SNCA promoter, we anticipated this region to be a driving force 217 behind the MB-specific expression of Snca. 218
To test this hypothesis, we assayed whether the central portion of this putative CRE, when lifted over to 219 hg19 (chr4:90,721,063-90,722,122), is capable of directing appropriate reporter expression in transgenic 220 zebrafish and mouse reporter assays. Stable transgenesis of zebrafish indicates that this CRE directs 221 reporter expression at 72 hours post fertilization in the locus coeruleus, a key population of 222 catecholaminergic neurons preferentially degenerated in PD 32 , and along the catecholaminergic tract 223 through the hindbrain, which is largely composed of DA neurons 33 (Figure 4c) . Additionally, we observe 224 reporter expression throughout the diencephalic catecholaminergic cluster with projections to the 225 subpallium, which is analogous to mammalian dopaminergic projections from the ventral midbrain to 226 the striatum 34 . Reporter expression in these transgenic zebrafish is largely consistent with an enhancer 227 active in catecholaminergic populations. 228
To further evaluate this CRE in a mammalian system, we generated lacZ reporter mice and examined 229 reporter activity across developmental time. Whole mount E12.5 reporter mice indicate this enhancer 230 directs exquisitely restricted expression in Th+ populations, including the dorsal root ganglia, extending 231 into the sympathetic chain, and throughout the cranial nerves (particularly the trigeminal). Additional 232 diffuse staining is noted throughout the MB and FB (Figure 4d) . Specifically examining the brains of lacZ 233 animals at E15.5, reporter expression is identified in the MB and hypothalamus, with strong expression 234 through the amygdala/piriform cortex and along the anterior portion of the sympathetic chain ( Figure  235 4e); similar reporter patterns are seen at P7 (Figure 4f) . At P30, we detect reporter activity in the 236 amygdala, hypothalamus, thalamus, periaqueductal grey area, brain stem, and importantly, in the 237 substantia nigra and ventral tegmental area (Figure 4g) . By contrast, in aged lacZ reporter mice (574 238 days old, ~19 months), we only detect strong reporter expression in the brain stem and observe weak 239 reporter expression in the amygdala (Figure 4h) . Collectively, the regions in which we detect reporter 240 activity reflect those compromised in PD; Lewy bodies (aggregates of α-synuclein) have been detected in 241 the locus coeruleus, sympathetic chain, amygdala, hypothalamus, ventral tegmental area, 242 periaqueductal grey area of PD patients [35] [36] [37] [38] [39] , and critically the preferential degradation of the substantia 243 nigra is the pathological hallmark of PD progression 2 . This enhancer directs region-specific appropriate 244 expression throughout development in key locations concordant with SNCA activity in PD pathogenesis. 245
Following confirmation of this CRE's regulatory activity in brain regions associated with PD, we next 246 inspected this sequence for PD-associated variation. We sequenced across this interval in 986 PD 247 patients and 992 controls and identified 14 variants (Supplemental Table 2 ), 4 of which were common 248 and present in both cases and controls with a minor allele frequency greater than 5%. Of these, two 249 tightly linked variants (r 2 = 0.934; Supplemental Table 3 ), rs2737024 (OR = 1.25, 95% CI = 1.09-1.44, p-250 value = 0.002) and rs2583959 (OR = 1.22, 95% CI = 1.06-1.40, p-value = 0.005), were significantly 251 associated with PD ( Table 1) . These data support a role for variation within the enhancer in conferring 252
PD risk. 253
To assess how these variants may impact enhancer function and thus PD risk, we assayed differential 254 protein binding at these variants for >20,000 proteins 40 . In doing so, we identify five proteins whose 255 binding is robustly impacted by these implicated variants: NOVA1, APOBEC3C, PEG10, SNRPA, and 256 CHMP5 (Figure 5a, b, c) . Of these, all are expressed at appreciable levels in both MB and FB DA neurons 257 (Figure 5d ), excluding APOBEC3C (RPKM ≤ 1). Of the remaining four proteins, three (PEG10, SNRPA, and 258 CHMP5) demonstrate an increased binding affinity for the minor risk allele over the major allele; this 259 direction of effect is consistent with the over-expression paradigm by which SNCA confers PD risk 8 . 260
Interestingly, CHMP5 is the sole protein we identify whose binding affinity is impacted by variant 261 rs2583959, and our group has recently implicated one of its family members, CHMP7, in conferring PD 262 risk 27 , perhaps indicating a role for this family of proteins in PD. Although no single protein stands out, 263 the increased affinity for the risk alleles of the identified enhancer variants by proteins expressed in DA 264 neurons is consistent with a potential mechanistic contribution to SNCA expression and therefore, PD 265 risk. 266
Finally, we set out to refine the haplotype structure and understand how this identified variation may be 267 interacting with other variants at this locus. A panel of common variants had previously been genotyped 268 across SNCA and PD-associated haplotypes were identified 41 . After genotyping our patients and controls 269 for a subset of this panel of variants in addition to all enhancer-associated variants identified by 270 sequencing ( Supplemental Table 4 ), we identified a single haplotype that was significantly associated 271 with PD (p-value = 0.003), with a higher observed frequency in PD patients (28.3%) compared to controls 272 (23.4%; Table 2 ). This haplotype implicates some of the same variants as in Guella et al. 41 (rs356220, 273 rs737029) but also implicates rs356225 and rs356168, and the two enhancer-associated variants. 274
Collectively, these data identify a catecholaminergic enhancer harbouring common variation that is part 275 of a larger haplotype associated with PD risk. 276
DISCUSSION 277
The identification and prioritization of biologically pertinent non-coding variation associated with 278 disease remains challenging. Recent studies by our and other groups have emphasized the importance 279 of cellular context in the identification of sequences harbouring biologically pertinent variation and the 280 genes they regulate. To this end, we used chromatin signatures from ex vivo isolated DA neurons to 281 reveal biologically active sequences that harbour non-coding variation contributing to PD risk. We 282 generated robust CRE catalogues for both MB and FB DA neurons, confirmed their capacity to act as 283 enhancers, identified motifs that confer their regulatory potential, and notably, identified two variants 284 located within a MB-specific enhancer that are associated with an increase in PD risk. 285
In contrast to strategies predicated solely on dissection of post-mortem tissues or on the differentiation 286 of cultured cells, we leveraged the use of transgenic reporter mice to specifically isolate Th-expressing 287 neurons from discrete neuroanatomical (FB and MB) domains. While our approach assays a more 288 refined population of DA neurons than would be achieved via gross dissection, recent single-cell RNA-289 seq analyses of these same cells make clear that even within these highly restricted MB and FB 290 populations there exist two primary cellular phenotypes 27 . The "homogenous" MB and FB populations 291 each are comprised of an immature neuroblast population and a more mature, domain specific, post-292 mitotic population of DA neurons. As such, our CRE catalogues capture the chromatin accessibility from 293 both of these states. These catalogues are demonstrably biologically relevant for our purposes, but 294 future studies requiring even greater homogeneity may wish to consider single-cell ATAC-seq to refine 295 these domains further 42 . 296
In our in silico validation of the catalogues, we established them to be enriched for both sequence 297 constraint and biological relevance in a manner consistent with function and their FB/MB origin. 298
Furthermore, these sequences are frequently domain appropriate enhancers, with each catalogue 299 capturing a large fraction (77%) of previously validated MB and FB enhancers. Although an abundance of 300 regions are shown to direct neuronal expression compared to those annotated as negative or non-301 neuronal, it is interesting to note that almost half of the sequences previously documented not to direct 302 expression in vivo are also represented in one or both of our catalogues. 303
Given the frequently dynamic nature of CRE activity, this overlap with negative regions likely results 304 from temporal differences in these assays. Our data indicates these regions are accessible at E15.5 but 305 the lacZ reporter assays were carried out at E11.5; regions that have been annotated as negative at 306 E11.5 may be active at later time points and, as such, appear in our catalogues. As we moved from these 307 unbiased functional comparisons to more highly selected ones, the potential impact of temporal 308 differences became more pronounced. In mouse transgenic reporter assays, two of five assayed 309 putative CREs direct detectable expression of lacZ in neuronal populations. Consistent with the 310 temporally dynamic nature of CREs, when these same regions are tested in zebrafish across multiple 311 developmental time points, we observe four of the five sequences to act as neuronal enhancers. 312
In examining the sequence composition underlying the ATAC-seq peaks, we illuminate powerful 313 vocabularies for both FB and MB DA neuron transcriptional regulatory control. Machine learning using 314 gkm-SVM prioritizes four transcription factor families (Rfx, Foxa1/2, Nr4a2, Ascl1/2) as those conveying 315 significant regulatory potential in the CRE catalogues. Of these, the Rfx family had not previously been 316 implicated in DA neuron biology. Although several of the Rfx family members have been annotated as 317 having expression in the cerebellum or fetal brain 43 , a role specifically in MB DA neurons has not 318 previously been appreciated. By contrast, Nr4a2 is canonically associated with MB DA neurons 25,26 , is 319 highly expressed in this population (139 RPKM), and was prioritized as a TF conferring regulatory 320 potential in these cells; however, TF footprinting fails to provide evidence supporting its activity. We 321 postulate that this lack of footprint may reflect the transient DNA binding dynamics of Nr4a2. 322
Transcription factors with short DNA residence times often fail to reveal footprints, and nuclear 323 receptors, such as Nr4a2, have markedly transient DNA interactions 44 . 324
Taken collectively, these data establish a robust biological platform in which PD-associated variation can 325 be evaluated. To this end, an obvious candidate to interrogate was an apparent MB-specific open 326 chromatin domain within intron 4 of the known PD-associated gene, SNCA. We assayed the activity of 327 this putative CRE in zebrafish and across the life course of mice and found it to be active in key 328 catecholaminergic structures injured in PD (e.g.: the substantia nigra and locus coeruleus), from mid-329 gestation until at least P30. Thereafter, the utilization of this enhancer in the brain is diminished and by 330 late life appears restricted to the brainstem and amygdala. By the time of clinical presentation, PD 331 patients have already lost a significant proportion (≥30%) of their nigral DA neurons 2,45 ; the observed 332 biology of this CRE is consistent with a progressive pathogenic influence acting early in life, rendering 333 these populations preferentially vulnerable to loss over an extensive period of time. 334
Sequencing this interval in PD cases and controls revealed two common variants (rs2737024 and 335 rs2583959) therein, individually associated with an increased risk of PD. Testing these variants for their 336 effect on protein binding, we identify five proteins whose binding is affected, three of which, PEG10, 337 SNRPA, and CHMP5, display greater affinity for the risk allele. Furthermore, we identify a larger 338 haplotype containing these variants, also significantly associated with PD risk. While none of the other 339 SNPs in this haplotype overlap with CREs identified in the DA neuron catalogues, variant rs356168 has 340 significant functional evidence of its activity and contribution to PD risk 46 . The same DHS correlation 341 analysis 21,31 that suggests an interaction between the SNCA promoter and our identified CRE, also 342 suggests an interaction between the SNCA promoter and the rs356168 variant. Additionally, ChIA-PET 343 data 31,47 indicates that sequence encompassing this variant may interact with our enhancer, suggesting a 344 potential co-operative mode of action; a paradigm recently proposed by Gupta and colleagues 48 at the 345 EDN1 locus. We propose that the variants within the enhancer, independently or in concert with other variation within the identified haplotype, may act throughout the lifespan to render key populations of 347 catecholaminergic neurons vulnerable, thus increasing PD risk in individuals harbouring this variation. 348
This work emphasizes the value of biologically informed, cell context-dependent guided searches for the 349 identification of disease associated and functional non-coding variation. Given the extent of non-coding 350 GWAS-identified variation, the need for strategies to prioritize variants for functional follow-up is 351 greater than ever. Here, we generate chromatin accessibility data from purified populations of DA 352 neurons to generate catalogues of putative CREs. We have demonstrated how these data can be used to (i-j) The third ranked motif likely corresponds to Ascl1, and while it fails to leave a robust TF footprint (k), there is clear enrichment of ATAC-seq signal overlapping genome-wide predicted Ascl1 binding sites (l). (m-n) Nr4a2, canonically associated with DA neuron biology, is identified as a highly expressed TF likely contributing to the regulatory potential of the putative CREs however, it fails to leave a TF footprint in the cut-site patterns around predicted motif sites (o) and is only mildly enriched for ATAC-seq reads over its predicted binding sites (p). Reporter activity is observed at P30 in the amygdala, hypothalamus and thalamus (Thal), brain stem (BS), substantia nigra (SN), ventral tegmental area (VTA), and the periaqueductal grey area (PAG). (h) In aged mice (P574), reporter expression is detected robustly in the brain stem and faintly in the amygdala.
Figure 5
Identification of proteins whose binding is impacted by the implicated PD-risk SNPs. (a, b) MA plots for both rs2737024 and rs2583959 indicating the magnitude of the effect of the minor and major allele on binding. Cut-off for differential binding: log 2 (major/minor) ≥ 1.5 or ≤ -1.5. (a) NOVA1 and APOBEC3C (green circles) bind at rs2737024 with greater affinity for the major allele, while PEG10 and SNRPA (red circles) have a greater affinity for the minor allele. (b) CHMP5 (red circle) has a greater affinity for the minor allele of rs2583959. (c) Representative images of the protein binding for each of the differentially bound proteins. (d) Expression analysis in the MB and FB DA neurons for each of the differentially bound proteins indicate Nova1, Peg10, Snrpa, and Chmp5 to be highly expressed in these populations, while none of the Apobec family member genes are expressed (RPKMs ≤ 1, data not shown). Red bar is the mean expression of the four replicates (black dots). River Laboratories. This same mating scheme was used to establish timed matings, generating litters for 371 assay; day on which vaginal plug is observed, E0.5. Adult AB zebrafish lines were maintained in system 372 water according to standard methods 49 . All work involving mice and zebrafish (husbandry, colony 373 maintenance, procedures, and euthanasia) were reviewed and pre-approved by the institutional care 374 and use committee. 375
Neural dissociation and FACS 376
Pregnant SW mice were euthanized at E15.5 and the embryos were removed and immediately placed in 377 Corporation). The tissue was dissociated in the papain solution for 30 minutes at 37°C, with gentle 384 trituration every 10 minutes using a sterile Pasteur pipette. Following dissociation, cells were passed 385 through a 40µm cell strainer into a 50mL conical, centrifuged for 5 minutes at 300g, resuspended in 386 albumin-inhibitor solution containing DNase, applied to a discontinuous density gradient, and 387 centrifuged for 6 minutes at 70g. The resulting cell pellet was resuspended in HBSS with Mg 2+ and Ca 2+ 388 and submitted to FACS. Aliquots of 50,000 EGFP+ cells were sorted directly into 300µL HBSS with Mg 2+ 389 and Ca 2+ with 10% FBS for ATAC-seq. Aliquots containing ≥50,000 EGFP+ cells were sorted into kit-390 provided lysis buffer for RNA-seq. This procedure was repeated such that a single aliquot of cells from 391 each region per litter were submitted to either ATAC-seq or bulk RNA-seq three times over for each 392 region. 393
ATAC-seq library preparation and quantification 394
ATAC-seq library preparation generally follows the steps as set out in the original ATAC-seq paper 17 with 395 minor modifications. Aliquots of 50,000 EGFP+ cells were centrifuged for 5 minutes at 4°C and 500g, 396 washed with 50µL of chilled PBS and centrifuged again for 5 minutes at 4°C and 500g. The cell pellet was 397 resuspended in lysis buffer, as set out in the protocol, and cells were left to lyse for 5 minutes at 4°C 398 before being centrifuged for 10 minutes at 4°C at 500g. The resulting nuclei pellet was transposed, as 399 written, using the transposase from the Nextera DNA Library Preparation Kit. 
RNA-seq library preparation and quantification 420
Total RNA was extracted using the Purelink RNA Micro Kit (Invitrogen). Following FACS isolation into kit-421 provided lysis buffer, samples were homogenized and RNA extraction proceeded using manufacturer's 422 recommendations. Total RNA integrity was determined using the RNA Pico Kit (Agilent). RNA samples 423 were sent to the Sidney Kimmel Comprehensive Cancer Center Next Generation Sequencing Core at 424 Johns Hopkins for library preparation, using the Ovation RNA-Seq System V2 (Nugen), and sequencing. 425
RNA-seq sequencing, alignment, and transcript quantification 426
Libraries were pooled and sequenced on Illumina's HiSeq 2500 in Rapid Run mode with 2x100bp reads 427 to an average depth of >90 million reads per library. Quality of sequencing was evaluated using FastQC. 428 FASTQ files were aligned to mm9 using HISAT2 53 (v2.0.1-beta) with --dta specified. RNA was extracted using the RNeasy Mini Kit (Qiagen), after sorting 50,000 cells directly into Buffer RLT. 438
Aliquots of 50,000 non-fluorescing cells were also collected and processed in parallel. 100ng of each 439 RNA sample was submitted to first strand cDNA synthesis using the SuperScript III First-Strand Synthesis 440 System for RT-PCR (Invitrogen), following the Oligo(dT) method. 441 Primers ( Supplementary Table 5 ) were designed using Primer-BLAST 59 under default parameters with 442 the requirement for exon-exon junction spanning specified. qPCR was performed using Power SYBR 443 Green Master Mix (Applied Biosystems). Reactions were run in triplicate, following default SYBR Green 444
Standard cycle specifications on the Viia7 Real-Time PCR System (Applied Biosystems). Relative 445 quantification followed the 2 -ΔΔCT method, normalizing results to Actb in the EGFP-aliquot of cells for 446 each region, respectively. 447
Correlation analysis between regions and within replicates 448
Peaks from all six ATAC-seq libraries and the two "Joint" ATAC-seq libraries were concatenated together, 449 sorted on the basis of chromosomal location, merged into a unified peak set 60 , and converted to 450 Simplified Annotation Format (SAF). Reads from each BAM file overlapping this unified peak set were 451 quantified with the Rsubread package "featureCounts" command, with the following options: 452 isPairedEnd = TRUE, requireBothEndsMapped = FALSE. Read counts were normalized for each library 453 using conditional quantile normalization 61 , accounting for library size, peak length, and peak GC content. 454
Pearson correlation co-efficients were calculated from this normalized count matrix and visualized using 455 corrplot 62 and RColorBrewer 63 and LSD 64 . 456
Sequence constraint analysis 457
Average phastCons 65 were calculated for the "Joint" peak file for both the MB and FB libraries using 458 regions were removed from the peak files. Next, to limit the number of regions submitted to GREAT 470 such that the binomial distribution for calculating fold enrichment values was still valid, peak files were 471 limited to the top 20,000 peaks on the basis of q-value. 472 Finally, in order to limit ourselves to the nearest expressed gene, we supplied a list of the TSSs of the 473 nearest expressed gene that are in the GREAT database. The list of genes and their TSSs used by GREAT 474 was downloaded from: 475 http://bejerano.stanford.edu/help/download/attachments/2752609/mm9.great3.0.genes.txt. Only 476 genes that are in this list with RPKM > 1 were considered as expressed. The nearest expressed gene to 477 each of the top 20,000 peaks was identified. Each peak is associated with its nearest expressed gene and 478 to ensure that GREAT only considered these nearest genes for analysis, we submitted these nearest 479 expressed gene's TSSs as a proxy for each peak. These proxy peaks were submitted to GREAT using the 480 NCBI build 37 (mm9) assembly, under whole genome background regions, with the single nearest gene 481 as the association rule, including curated regulatory domains.
